JPMorgan Chase & Co’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,500
| Closed | -$13K | – | 5020 |
|
|
2018
Q2 | $13K | Sell |
5,500
-6,178
| -53% | -$14.6K | ﹤0.01% | 4583 |
|
|
2018
Q1 | $37K | Buy |
+11,678
| New | +$37K | ﹤0.01% | 4249 |
|
|
2017
Q3 | – | Sell |
-83,345
| Closed | -$277K | – | 4617 |
|
|
2017
Q2 | $277K | Buy |
83,345
+77,886
| +1,427% | +$259K | ﹤0.01% | 3312 |
|
|
2017
Q1 | $50K | Hold |
5,459
| – | – | ﹤0.01% | 3929 |
|
|
2016
Q4 | $42K | Sell |
5,459
-222
| -4% | -$1.71K | ﹤0.01% | 4058 |
|
|
2016
Q3 | $65K | Sell |
5,681
-379
| -6% | -$4.34K | ﹤0.01% | 3537 |
|
|
2016
Q2 | $74K | Sell |
6,060
-38,182
| -86% | -$466K | ﹤0.01% | 3443 |
|
|
2016
Q1 | $447K | Sell |
44,242
-94,936
| -68% | -$959K | ﹤0.01% | 2942 |
|
|
2015
Q4 | $3.14M | Buy |
+139,178
| New | +$3.14M | ﹤0.01% | 2174 |
|
|
2015
Q3 | – | Sell |
-112,283
| Closed | -$2.53M | – | 3623 |
|
|
2015
Q2 | $2.53M | Buy |
112,283
+29,036
| +35% | +$653K | ﹤0.01% | 2402 |
|
|
2015
Q1 | $2.15M | Buy |
+83,247
| New | +$2.15M | ﹤0.01% | 2495 |
|
|
2014
Q4 | – | Sell |
-43,785
| Closed | -$829K | – | 3684 |
|
|
2014
Q3 | $829K | Buy |
43,785
+21,071
| +93% | +$399K | ﹤0.01% | 2824 |
|
|
2014
Q2 | $529K | Buy |
+22,714
| New | +$529K | ﹤0.01% | 3017 |
|
|
2013
Q4 | – | Sell |
-99,775
| Closed | -$1.53M | – | 4032 |
|
|
2013
Q3 | $1.53M | Buy |
+99,775
| New | +$1.53M | ﹤0.01% | 2742 |
|